³Ô¹ÏÍøÕ¾

South Australia Covid update as at 28 April 2023

COVID Cases in SA

There have been 2,674 new cases of COVID-19 reported in South Australia in the past week.

As of 11:59pm Thursday 27 April, there were 134 people with COVID-19 in hospital, including three people in ICU and one person ventilated.

There were seven COVID-19 deaths notified in the past week, the ages range from people in their 60s to over the age of 100. Deaths may not have occurred in the week in which they were reported.

Please note that due to a reconfiguration of the data, the total number of cases has been readjusted.

Total case breakdown

{​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​{​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​table.title}​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​}​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​This weekPrevious week
New cases2,6742,509
Total cases903,240900,575
Total deaths1,419*1,413

*One death has been removed from the total due to previously reported deaths found to be unrelated to COVID-19

Variants

The latest genome sampling has found 61.9% of samples analysed were BA.2 and related variants (of which 10% were BA.2.7.5 and 90% were XBB), 30.6% were XBB.1.5 and 1.1% of samples analysed were BA.5 and related variants.

Other recombinant types made up 36.3% of the total variants (of which 93.8% were the XBC variant).

COVID testing

In the past week, 7,522 people received a PCR test in South Australia, a 42% decrease on the previous week.

Of the test results returned, 883 PCR tests were positive and 1,791 positive Rapid Antigen Test results were reported.

Vaccination update

Data is available from .

COVID testing sites

There are more than 40 sites across the state where South Australians can access a PCR with and without a GP referral.

This includes new walk-in clinics at Salisbury and Brighton, Frome Road in Adelaide, and Mount Barker where people can get a free PCR without a referral.

Bookings are preferred.

PCR testing should be prioritised for people who are more vulnerable to the health impacts of a COVID infection and who would benefit from prompt diagnosis and treatment with oral antiviral medications.

/Public Release. View in full .